Hantz Financial Services’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86K Buy
870
+559
+180% +$72.9K ﹤0.01% 1337
2025
Q4
$38K Buy
311
+206
+196% +$25.9K ﹤0.01% 1547
2025
Q3
$12K Buy
105
+91
+650% +$10.7K ﹤0.01% 1778
2025
Q2
$2K Buy
14
+12
+600% +$1.32K ﹤0.01% 2032
2025
Q1
$0 Buy
+2
New +$138 ﹤0.01% 1968
2021
Q3
Sell
-15
Closed 859
2021
Q2
$0 Buy
+15
New +$416 ﹤0.01% 844

Other funds holding TMDX

Hantz Financial Services's TMDX Position: Q1 2026 in Review

Hantz Financial Services increased its Transmedics (TMDX) stake by 180% in Q1 2026, buying an estimated $72.9K and bringing the position to 870 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Hantz Financial Services first reported a position in TMDX in Q2 2021 and has held it in 6 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Hantz Financial Services held 870 shares of Transmedics worth $86K as of Q1 2026.
  • Hantz Financial Services bought 559 Transmedics shares in Q1 2026, an estimated $72.9K.
  • Transmedics made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #1337 holding.
  • Hantz Financial Services first reported a position in Transmedics in Q2 2021 and has held it in 6 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.